SABMiller’s Mackay Steps Back After ‘Sudden Worsening’ of Health
SABMiller Plc, (SAB) the world’s second-biggest brewer, said Chairman Graham Mackay is taking a further leave of absence after a “recent sudden worsening” of his health following brain surgery earlier this year.
Deputy Chairman John Manser has been re-appointed as acting chairman, a role he held for five months during Mackay’s initial recovery, the London-based company said today in a statement.
Mackay only returned as chairman two months ago, having been off work following treatment for a brain tumor.
In April, he stepped down early as the brewer’s chief executive officer, a role in which he masterminded a slew of acquisitions, including the A$10.5 billion ($9.8 billion) takeover of Foster’s Group Ltd. in 2011. Alan Clark, a company veteran of more than two decades, replaced Mackay as CEO.
To contact the editor responsible for this story: Celeste Perri at firstname.lastname@example.org